Type Here to Get Search Results !

CDC expedites release of more doses of infant RSV drug from Sanofi, AstraZeneca amid shortage

The CDC's move to increase availability of Beyfortus, a monoclonal antibody from Sanofi and AstraZeneca, comes as RSV cases rise in some parts of the country.

from Business News https://ift.tt/PERWJjo

Post a Comment

0 Comments
* Please Don't Spam Here. All the Comments are Reviewed by Admin.